Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 20, 2025

Study Completion Date

December 20, 2025

Conditions
Pancreatic Diseases
Interventions
OTHER

Placebo

Placebo tablets will have the same look and appearance of ondansetron.

DRUG

Ondansetron

ondansetron is commonly used as anti-emetics to prevent and treat chemotherapy-induced vomiting and nausea

Trial Locations (1)

31527

RECRUITING

Tanta Unuversity, Tanta

All Listed Sponsors
lead

Tanta University

OTHER